
Structural Heart Disease Device Developer
On November 8, the opening of Nantong's first "Jianghai Craftsman Innovation Week" and the exhibition and exchange event for employee scientific and technological innovation achievements were successfully held. With the theme of "Ingenious Creation of 'New' · 'Quality' Initiating the Future," the event was jointly organized by the Nantong Federation of Trade Unions and the Nantong Human Resources and Social Security Bureau. It aimed to thoroughly implement the important instructions of President Xi Jinping on advancing the reform of industrial worker team building and cultivating master craftsmen, stimulating employees' scientific and technological innovation vitality, and encouraging and guiding workers to strengthen their skills through diligent study and hard practice, striving to become technical experts and great craftsmen.Trulive's One-Stop Toolbox for Blood Flow Management Innovative Solution Invited to Exhibit, Multiple Breakthrough Products Made a Stunning Debut and Captivated the Audience.
During the event,Wu Xinming, Secretary of the Municipal Party CommitteeDuring the visit to the innovation achievements exhibition, Secretary Wu carefully observed the exhibits and learned in detail about the construction of the employee innovation system, the application of innovative achievements, and the training of skilled personnel. During the visit, Secretary Wu stopped at the Trulive booth. Through detailed product explanations and impressive live demonstrations by the project representative, the significant breakthroughs of Trulive's products in design concept, technological innovation, and performance improvement were fully showcased, demonstrating the unique charm of self-developed products made in China to the leaders present. Secretary Wu encouraged the company to keep up the good work, continue to focus on the transformation of scientific and technological achievements and integrated innovation, allowing innovative achievements to benefit society.

Trulive's independently developed innovative products have enormous application prospects in the Chinese market. With the intensification of China’s aging population, the number of patients with cardiovascular and structural heart diseases continues to grow. Trulive's one-stop innovative solution for blood flow management is expected to become the preferred solution for addressing cardiovascular diseases, bringing new vitality to the field of cardiovascular interventional treatment in China. In the future, Trulive will continue to advance independent innovation, address significant unmet clinical needs, and provide high-quality, innovative medical solutions for Chinese patients, contributing to enhancing the global influence of China's high-end medical devices!
-End-
Trulive
Jiangsu Trulive Medtech Co., Ltd. is a leading cardiovascular intervention platform company in China. The company focuses on cardiovascular disease areas with extremely high mortality and disability rates, where domestically produced products are still lacking. Its business comprehensively covers four major disease areas: heart valves, heart failure, peripheral vascular, and coronary artery diseases, making it the first domestic platform-based high-end medical device company to fully cover these four key fields with core products achieving substantial progress. With strong research and development capabilities and an experienced, complete operational team, Trulive has developed high-quality, proprietary medical devices and comprehensive solutions with independent intellectual property rights, filling the gap in China’s high-end vascular intervention medical device market. It provides Chinese doctors and patients with more advanced and diverse treatment options, offering "Chinese solutions" and contributing "Chinese wisdom" in many细分 markets长期被进口产品垄断的细分市场中细分 markets long monopolized by imported products within the cardiovascular intervention field.

Scan to follow us
Business Cooperation | 021-50625001-8930
Email Address | vicky.z@trulive.cn